96 related articles for article (PubMed ID: 17347333)
1. Safety, antigenicity, and efficacy of a recombinant coccidioidomycosis vaccine in cynomolgus macaques (Macaca fascicularis).
Johnson SM; Lerche NW; Pappagianis D; Yee JL; Galgiani JN; Hector RF
Ann N Y Acad Sci; 2007 Sep; 1111():290-300. PubMed ID: 17347333
[TBL] [Abstract][Full Text] [Related]
2. Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection.
Xue J; Hung CY; Yu JJ; Cole GT
Vaccine; 2005 May; 23(27):3535-44. PubMed ID: 15855012
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of intranasal vaccination with recombinant chain A ricin vaccine (rRV) in mice by the mucosal adjuvants LTK63 and LTR72.
Kende M; Tan X; Wlazlowski C; Williams R; Lindsey C; Del Giudice G
Vaccine; 2007 Apr; 25(16):3219-27. PubMed ID: 17343960
[TBL] [Abstract][Full Text] [Related]
4. Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein.
Shubitz LF; Yu JJ; Hung CY; Kirkland TN; Peng T; Perrill R; Simons J; Xue J; Herr RA; Cole GT; Galgiani JN
Vaccine; 2006 Jul; 24(31-32):5904-11. PubMed ID: 16759762
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of the protective subcellular coccidioidal T27K vaccine.
Johnson SM; Kerekes KM; Lunetta JM; Pappagianis D
Ann N Y Acad Sci; 2007 Sep; 1111():275-89. PubMed ID: 17363436
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell-based vaccine against coccidioides infection.
Awasthi S
Ann N Y Acad Sci; 2007 Sep; 1111():269-74. PubMed ID: 17363430
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of recombinant anthrax vaccine against Bacillus anthracis aerosol spore challenge: preclinical evaluation in rabbits and Rhesus monkeys.
Chawla A; Midha S; Bhatnagar R
Biotechnol J; 2009 Mar; 4(3):391-9. PubMed ID: 19296443
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of immune responses and protective efficacy in a goat model following immunization with a coctail of recombinant antigens and a polyprotein of Mycobacterium avium subsp. paratuberculosis.
Kathaperumal K; Kumanan V; McDonough S; Chen LH; Park SU; Moreira MA; Akey B; Huntley J; Chang CF; Chang YF
Vaccine; 2009 Jan; 27(1):123-35. PubMed ID: 18955101
[TBL] [Abstract][Full Text] [Related]
9. Molecular and cellular mechanisms of protective immunity to coccidioidomycosis.
Kirkland TN; Raz E; Datta SK
Vaccine; 2006 Jan; 24(4):495-500. PubMed ID: 16181709
[TBL] [Abstract][Full Text] [Related]
10. Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.
Jiang C; Magee DM; Quitugua TN; Cox RA
Infect Immun; 1999 Feb; 67(2):630-5. PubMed ID: 9916069
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.
Herr RA; Hung CY; Cole GT
Infect Immun; 2007 Dec; 75(12):5777-87. PubMed ID: 17875631
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta].
Bharati K; Rani R; Vrati S
Vaccine; 2009 Jan; 27(1):10-6. PubMed ID: 18996161
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a live attenuated tetravalent candidate dengue vaccine in naïve and previously infected cynomolgus macaques.
Koraka P; Benton S; van Amerongen G; Stittelaar KJ; Osterhaus AD
Vaccine; 2007 Jul; 25(29):5409-16. PubMed ID: 17560694
[TBL] [Abstract][Full Text] [Related]
14. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
[TBL] [Abstract][Full Text] [Related]
15. Amended recombinant cells (ARCs) expressing bovine IFN-gamma: an economical and highly effective adjuvant system.
Gaertner FH; Babiuk LA; Mutwiri G; Armstrong JM; Griebel PJ
Vaccine; 2009 Feb; 27(9):1377-85. PubMed ID: 19150640
[TBL] [Abstract][Full Text] [Related]
16. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
Jafarzadeh A; Zarei S; Shokri F
Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
[TBL] [Abstract][Full Text] [Related]
17. Recombinant Mycobacterium bovis BCG vector system expressing SIV Gag protein stably and persistently induces antigen-specific humoral immune response concomitant with IFN gamma response, even at three years after immunization.
Kawahara M
Clin Immunol; 2008 Dec; 129(3):492-8. PubMed ID: 18849196
[TBL] [Abstract][Full Text] [Related]
18. The public health need and present status of a vaccine for the prevention of coccidioidomycosis.
Hector R; Rutherford GW
Ann N Y Acad Sci; 2007 Sep; 1111():259-68. PubMed ID: 17344529
[TBL] [Abstract][Full Text] [Related]
19. [Cellular immune responses of recombinant hepatitis B (rHB) vaccine and HBsAG derived from Hansenula polymorpha cells].
Hu ZY; He P; Zhang R; Fang X; Zhu FC; Qiu SH; Li HM; Wang H; Liang ZL; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jul; 29(7):706-11. PubMed ID: 19031766
[TBL] [Abstract][Full Text] [Related]
20. Aerosol measles vaccination in macaques: preclinical studies of immune responses and safety.
de Swart RL; Kuiken T; Fernandez-de Castro J; Papania MJ; Bennett JV; Valdespino JL; Minor P; Witham CL; Yüksel S; Vos H; van Amerongen G; Osterhaus AD
Vaccine; 2006 Sep; 24(40-41):6424-36. PubMed ID: 16934375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]